Max Healthcare
Max Healthcare Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
2 of 4 strong
Not discussed on this call: order book.
The short version
Continued capacity expansion across key locations (Lucknow, Noida, Nagpur) leading to higher occupancy and revenue growth. Revenue growth momentum remains strong with 16% year-on-year growth in Q1 FY27.
From Max Healthcare's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Continued capacity expansion across key locations (Lucknow, Noida, Nagpur) leading to higher occupancy and revenue growth.
- New brownfield capacity additions expected to contribute directly to bottom-line profitability.
- Incremental beds being added at Nanavati and Max Smart, with occupancy ramping up to around 80%, suggesting strong revenue and EBITDA growth potential.
- Commissioning of new hospital beds phased over quarters, with EBITDA impact expected from Q2-Q3 onward.
- Long-term outlook supports steady ARPOB growth of 7-8%, outpacing inflation due to innovation and novel treatments.
- Institutional revenue share expected to decline gradually due to changing mix.
- Planned capital expenditure on new hospital towers (e.g., Max Vaishali) enhancing bed capacity before FY30.
- Expansion into medical education business anticipated to generate new revenue streams in the coming years.
Profitability & Margins
See what Max Healthcare said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Approved capex of INR 425 crore for a new brownfield tower at Max Vaishali adding 202 beds; construction started, commissioning expected before FY30.
- Ongoing capacity expansions include:
- - 100 beds at Max Lucknow (commissioning next two quarters)
- - 500 beds at Sector 56 Gurgaon (phased commissioning from end of this year)
- - 250 beds at Bhubaneswar (renovations to complete within 12 months)
- - 100 beds at Nagpur (commissioning by FY28)
- - 400 beds at Zirakpur, Mohali (commissioning in FY28)
- - Onco day care block at Max Dwarka (awaiting occupancy certificate)
- - 260 beds at Dwarka (commission by FY30)
- - 200 beds at Pitampura (commission by FY29)
- - 400 beds at Patparganj (work started, commissioning by end FY29)
- - 271 beds at Nanavati Phase 2 (commission by FY30)
- - 450 beds at Pune (IOD received, commissioning by FY30)
- Plans to start medical education business with significant capex (~INR 300 crore per 150-seat college) funded through internal accruals.
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Max Healthcare said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Max Healthcare — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹2.1K Cr, net profit ₹342 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Max Healthcare Institute Ltd's management said in earlier quarters
- Q3 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q4 FY25 earnings call analysis →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
Others in Healthcare Services this season
- Manipal Health Enterprises Ltd (Q1 FY27)
Volume-led growth with inpatient (IP) volumes up 39% and outpatient (OP) volumes up 26% year-on-year. Key concall takeaways from Manipal Health Enterprises…
- Fortis Healthcare Ltd (Q1 FY27)
IHH plans to increase its stake in Fortis to over 50% within 3-5 years, supporting long-term strategic growth. Key concall takeaways from Fortis Healthcare…
- Metropolis Healthcare Ltd (Q1 FY27)
East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…
- Apollo Hospitals Enterprise Ltd (Q1 FY27)
IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…
Frequently Asked Questions
What were Max Healthcare Q1 FY27 results?
Continued capacity expansion across key locations (Lucknow, Noida, Nagpur) leading to higher occupancy and revenue growth. Revenue growth momentum remains strong with 16% year-on-year growth in Q1 FY27.
What is Max Healthcare share price analysis?
Max Healthcare currently shows a below-average growth signal. The stock trades at a P/E of 65.0 with a market cap of ₹97,328 Cr. Investors should review the full earnings analysis for detailed insights.
Is Max Healthcare planning capital expenditure?
Approved capex of INR 425 crore for a new brownfield tower at Max Vaishali adding 202 beds; construction started, commissioning expected before FY30.
Keep Max Healthcare on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
